CPHbiomedix ApS: Financial statements 2024
CVR: 43118676
CPHbiomedix ApS (CVR 43118676) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,138,643 and a net result of DKK 237,468 compared with DKK 279,483 the year before. That is a decrease of 11.9% compared with the year before. Equity amounted to DKK 3,577,343. The solvency ratio was 94.4%. The company had 1 employee in the financial year.
- Gross Profit
- 1,138,643 kr.
- Profit/Loss
- 237,468 kr.
- Equity
- 3,577,343 kr.
- Total Assets
- 3,789,280 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.1 mio. | 237 t. | 3.6 mio. | 1 |
| 2023 | - | 1.3 mio. | 279 t. | 3.3 mio. | 1 |
| 2022 | - | 1.3 mio. | 314 t. | 3.1 mio. | 1 |
How creditworthy is CPHbiomedix ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
CPHbiomedix ApS has published its annual report for 2023. Gross profit came to DKK 1,291,883, and the net result was DKK 279,483.
About CPHbiomedix ApS
CPHbiomedix ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Claus Bo Vöge Christensen. The company is owned by Claus Bo Vöge Christensen. In 2025, the company reported a gross profit of DKK 473,967 and a net result of DKK -21,956 compared with DKK 237,468 the year before. Equity amounted to DKK 3,555,387.
